人脐带间充质干细胞对宫颈癌HeLa细胞增殖和凋亡的影响及其作用机制

doi:10.13481/j.1671-587X.20210515

摘要/Abstract

摘要： 目的

探讨人脐带间充质干细胞（MSCs）对宫颈癌HeLa细胞增殖和凋亡的影响，阐明其可能的作用机制。

方法

分离培养人脐带MSCs，采用光学显微镜观察细胞形态表现，并采用流式细胞仪分析鉴定其表面抗原标记物CD90、CD105、CD34和CD45的表达，以未加一抗仅加二抗的MSCs为平行对照组。将20%和60%浓度的MSCs条件培养基和宫颈癌HeLa细胞共培养72 h，集落形成实验观察MSCs条件培养基作用下HeLa细胞集落的形成能力；CCK-8实验检测HeLa细胞增殖抑制率；流式细胞术检测HeLa细胞凋亡率；蛋白质印迹法检测MSCs条件培养基作用下HeLa细胞增殖和凋亡相关基因蛋白表达水平。

结果

脐带分离细胞接种72 h后有少量细胞贴壁，1周后逐渐变成扁平单层细胞，呈簇状和旋涡状生长，伴随细胞密度增加，细胞体随之变细长，形态与成纤维细胞类似。MSCs细胞表面抗原标记物CD90和CD105呈阳性表达，CD34和CD45呈阴性表达，符合干细胞表型。集落形成实验，加入20%和60%的MSCs条件培养基，宫颈癌HeLa细胞集落形成的抑制率分别为18.56%和37.64%。与对照组比较，MSCs处理48 h后宫颈癌HeLa细胞早期凋亡率升高（P<0.05）。MSCs处理0、24和48 h后HeLa细胞中半胱天冬氨酸蛋白酶3（caspase-3）和P53蛋白表达水平持续升高（P<0.05），B细胞淋巴瘤2（Bcl-2）蛋白相对表达水平持续降低（P<0.05）。

结论

MSCs体外可抑制宫颈癌HeLa细胞增殖，并诱导HeLa细胞凋亡，其机制可能与上调促凋亡分子caspase-3与P53表达、下调抗凋亡因子Bcl-2表达有关。

关键词: 宫颈肿瘤, 人脐带间充质干细胞, 细胞增殖, 细胞凋亡

Abstract: Objective

To investigate the effect of human umbilical cord mesenchymal stem cells （MSCs） on the proliferation and apoptosis of cervical cancer HeLa cells， and to elucidate its possible mechanism.

Methods

The human umbilical cord MSCs were isolated and cultured. The morphology of cells were observed by light microscope. The expressions of surface antigen markers CD90， CD105， CD34 and CD45 were identified by flow cytometry. The MSCs were added with second antibody （without first antibody） were used as parallel control group.The conditioned medium containing 20% and 60% MSCs and cervical cancer HeLa cells were co-cultured for 72 h， colony formation experiment was used to observe the colony forming ability of HeLa cells after treated with of MSCs conditioned medium.CCK-8 experiment was used to detect the inhibitory rates of proliferation of the HeLa cells. Flow cytometry was used to detect the apoptotic rates of HeLa cells. Western blotting method was used to detect the expression levels of proliferation- and apoptosis-related gene proteins in the HeLa cellsn.

Results

After 72 h of inoculation， a small number of cells adhered to the wall， and gradually became flat monolayer cells， which grew in clusters and vortices after one week. With the increase of cell density， the cell body became slender， similar to that of fibroblasts.The MSCs showed positive expressions of CD90 and CD105， but negative expressions of CD34 and CD45， which conformed to the phenotype of stem cells.The results of colony formation test showed that the inhibitory rates of colony formation of HeLa cells were 18.56% and 37.64% respectively when the conditioned medium containing 20% and 60% MSCs were added.Compared with control group，the early apoptotic rate of HeLa cells after treated with MSCs for 48 h was increased （P<0.05）. After the HeLa cells were treated with MSCs for 0， 24 and 48 h， the expression levels of cysteinyl aspartate-specific proteinase-3 （Caspase-3） and P53 proteins were increased continuously （P<0.05）， and the expression levels of B-cell lymphoma-2 （Bcl-2） protein were decreased continuously （P<0.05）.

Conclusion

The MSCs can inhibit the proliferation of HeLa cells and induce the apoptosis of HeLa cells in vitro，and its mechanism may be related to up-regulating the expression of Caspase-3 and P53 and down-regulating the expression of anti-apoptotic factor Bcl-2.

Key words: cervical cancer, human umbilical cord mesenchymal stem cells, cell proliferation, cell apoptosis

中图分类号:

R285.5

王琛,田君,程海玲. 人脐带间充质干细胞对宫颈癌HeLa细胞增殖和凋亡的影响及其作用机制[J]. 吉林大学学报(医学版), 2021, 47(5): 1187-1193.

Chen WANG,Jun TIAN,Hailing CHENG. Effect of human umbilical cord mesenchymal stem cells on proliferation and apoptosis of cervical cancer HeLa cells and its mechanism[J]. Journal of Jilin University(Medicine Edition), 2021, 47(5): 1187-1193.

图/表 7

图1

图2

图3

图4

图5

表1

图6

参考文献 21

1	MUNIR S， BASU A， MAITY P， et al. TLR4-dependent shaping of the wound site by MSCs accelerates wound healing［J］.EMBO Rep，2020，21（5）：e48777.
2	JIANG D， SINGH K， MUSCHHAMMER J， et al. MSCs rescue impaired wound healing in a murine LAD1 model by adaptive responses to low TGF-β1 levels［J］. EMBO Rep，2020， 21（4）：e49115.
3	CAO X， DUAN L， HOU H， et al. IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization［J］. Theranostics，2020， 10（17）：7697-7709.
4	LIU S， LIU F， ZHOU Y， et al. Immunosuppressive property of MSCs mediated by cell surface receptors［J］. Front Immunol， 2020， 11：1076.
5	ZHAO Q， ZHANG L， WEI Y， et al. Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease［J］. Stem Cell Res Ther，2019， 10（1）：354.
6	BRISSON M， KIM JJ， CANFELL K， et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination： a comparative modelling analysis in 78 low-income and lower-middle-income countries［J］. Lancet， 2020， 395（10224）：575-590.
7	ANNAN FM， OPPONG ASANTE K， KUGBEY N. Perceived seriousness mediates the influence of cervical cancer knowledge on screening practices among female university students in Ghana［J］. BMC Womens Health， 2019， 19（1）：140.
8	NIGUSSIE T， ADMASSU B， NIGUSSIE A. Cervical cancer screening service utilization and associated factors among age-eligible women in Jimma town using health belief model， South West Ethiopia［J］. BMC Womens Health， 2019， 19（1）：127.
9	ASSEFA A A， ASTAWESEGN F H， ESHETU B. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities， Hawassa town， Ethiopia： a cross-sectional study［J］. BMC Health Serv Res， 2019， 19（1）：847.
10	郭娜娜，高晨，陈蕾. Polo样激酶1（PLK1）的敲低及其对宫颈癌HeLa细胞生长的抑制作用［J］. 细胞与分子免疫学杂志， 2018， 34（4）：334-340.
11	HOMBACH AA， GEUMANN U， GÜNTHER C，et al. IL7-IL12 engineered mesenchymal stem cells （MSCs） improve A CAR T cell attack against colorectal cancer cells［J］. Cells， 2020， 9（4）：873.
12	HULL R， MBELE M， MAKHAFOLA T， et al. Cervical cancer in low and middle-income countries［J］. Oncol Lett，2020， 20（3）：2058-2074.
13	MCKENZIE BA， FERNANDES JP， DOAN MAL，et al.Activation of the executioner caspases-3 and -7 promotes microglial pyroptosis in models of multiple sclerosis［J］. J Neuroinflammation， 2020， 17（1）：253.
14	TUMMERS B， MARI L， GUY CS， et al. Caspase-8-dependent inflammatory responses are controlled by its adaptor， FADD， and necroptosis［J］. Immunity， 2020， 52（6）：994-1006.
15	LI Z， GUO D， YIN X， et al. Zinc oxide nanoparticles induce human multiple myeloma cell death via reactive oxygen species and Cyt-C/Apaf-1/Caspase-9/Caspase-3 signaling pathway in vitro ［J］. Biomed Pharmacother， 2020， 122：109712.
16	JUNG JH， LEE H， Cao B， et al. RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating P53［J］. Oncogene， 2020，39（5）：1031-1040.
17	ZHANG Y， XU L， CHANG Y， et al. Therapeutic potential of ReACP53 targeting mutant P53 protein in CRPC［J］. Prostate Cancer Prostatic Dis， 2020， 23（1）：160-171.
18	WEI W， LIU C. Prognostic and predictive roles of microRNA‑411 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the P53 signaling pathway in cervical cancer［J］. Mol Med Rep， 2020， 21（1）：267-281.
19	金红，杨岚，张黎，等. 双氢青蒿素和吉非替尼联用对肺癌NCI-H1975细胞凋亡相关蛋白Bax与Bcl-2表达的影响［J］. 中国老年学杂志， 2019， 39（23）：5806-5810.
20	陈浩然.血小板凋亡机制对抗肿瘤药物引起血小板减少症的作用研究进展［J］.解放军医学杂志，2019，44（1）：80-85.
21	赖银璇，王明蕊，杨海丽，等. 柚皮素通过ROS/JNK/Bcl2通路抑制宫颈癌HeLa细胞增殖和迁移［J］. 中药药理与临床， 2018， 34（1）： 40-43.

Time(t/h)	Caspase-3	P53	Bcl-2
0	0.09±0.01	0.08±0.01	0.59±0.08
24	0.33±0.05^*	0.52±0.09^*	0.42±0.07^*
48	0.66±0.09^*△	0.71±0.06^*△	0.31±0.06^*△
F	68.888	79.653	20.034
P	<0.01	<0.01	<0.01

[1]	王志娟,张明姝,叶丽平. 血小板衍生生长因子D通过ERK信号通路对肺癌H1299细胞增殖、迁移和侵袭的影响及其机制[J]. 吉林大学学报(医学版), 2022, 48(4): 898-904.
[2]	郎庆旭,牛雪霜,杨凯文,张韧,王思腾,祖米热提古丽·吾买尔null,王珍琦. 丁酸钠联合电离辐射对肺癌A549细胞凋亡的影响及其机制[J]. 吉林大学学报(医学版), 2022, 48(4): 915-921.
[3]	马琰迪,卢香云,何尚峰,俞雪燕,胡云华,高海霞,陈云昭,禹洁,王文洁,李锋,崔晓宾. m6A甲基化修饰结合蛋白YTHDF2在食管癌组织中的表达及其对食管癌细胞增殖和迁移的影响[J]. 吉林大学学报(医学版), 2022, 48(4): 962-970.
[4]	汪国武,姚远,张雨,徐娜,刘芳. miR-152降低低密度脂蛋白受体表达对子宫内膜癌细胞增殖和侵袭的抑制作用[J]. 吉林大学学报(医学版), 2022, 48(3): 591-599.
[5]	李官虎,郎庆旭,刘纯岩,刘沁,耿梦柔,李晓倩,王珍琦. 丙戊酸联合X射线照射对乳腺癌MDA-MB-231细胞增殖的抑制作用及其机制[J]. 吉林大学学报(医学版), 2022, 48(3): 622-629.
[6]	颜培玉,张爱臣,章宏,李杨,张萌萌,洛梦泽,潘颖. 脂肪间充质干细胞对卵巢早衰模型大鼠的治疗作用及其机制[J]. 吉林大学学报(医学版), 2022, 48(3): 648-656.
[7]	曹秋婷,韩竞春,张晓飞. 沉默解旋酶BLM基因对结直肠癌细胞伊立替康化疗敏感性的影响及其机制[J]. 吉林大学学报(医学版), 2022, 48(3): 657-667.
[8]	刘翠兰,胡凤爱,刘晶,王丹,邱长云,柳敦江,赵娣. 脂联素受体激动剂AdiopRon对胶质瘤细胞生物学行为的影响及其机制[J]. 吉林大学学报(医学版), 2022, 48(3): 702-710.
[9]	杨明星,董文,李冀. 贝母素乙对肺癌A549细胞凋亡的诱导作用及其机制[J]. 吉林大学学报(医学版), 2022, 48(3): 711-717.
[10]	吴壮志,贺小宁,陈思祺. miR-124-3p对口腔鳞状细胞癌细胞增殖和侵袭的抑制作用及其机制[J]. 吉林大学学报(医学版), 2022, 48(3): 718-727.
[11]	李明,王秋婷,陈山,石慧芳. p38 MAPK抑制剂通过抑制NLRP3途径介导的细胞焦亡对小鼠慢性阻塞性肺疾病损伤的改善作用[J]. 吉林大学学报(医学版), 2022, 48(3): 744-754.
[12]	陈素贤,谷泽慧,马炀斐,谭琦,李琪,王亚帝. 芦丁对人结肠癌SW480细胞凋亡的促进作用及其作用机制[J]. 吉林大学学报(医学版), 2022, 48(2): 356-363.
[13]	赵智慧,白香花,何金玲,段伟琴,刘敏,张生茂. 舒芬太尼对心肌缺血再灌注损伤大鼠心肌细胞凋亡的抑制作用及其作用机制[J]. 吉林大学学报(医学版), 2022, 48(2): 364-373.
[14]	李小燕,张维,何杰. REG1A通过调控Wnt/β-catenin信号通路对肺腺癌细胞增殖和迁移的促进作用[J]. 吉林大学学报(医学版), 2022, 48(2): 444-453.
[15]	许广松,蒋海兵,盘箐,李国庆. 桦木酸对胃癌MGC-803细胞迁移和侵袭的抑制作用及其机制[J]. 吉林大学学报(医学版), 2022, 48(1): 122-128.